AbCellera Biologics Inc.

NASDAQ:ABCL

Biotechnology

Healthcare
$10.47 -0.28%

-$0.02 today

Market cap
$3.42B
Beta
1.20
P/E (TTM)
-11.4
EPS (TTM)
-$0.47
52W Low $2.75High $6.79

Volume 2.48M

Average 6.37M

Price history

AbCellera Biologics Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+207.04%

Period high

$14.82

Period low

$2.78

Latest

$10.47

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
4Nov 13, 2026Nov 13, 2026
4Nov 13, 2026Nov 13, 2026
SC 13G/ANov 13, 2026Nov 13, 2026
4Nov 12, 2026Nov 12, 2026
8-KNov 9, 2026Nov 9, 2026
10-QNov 9, 2026Nov 9, 2026
4Aug 24, 2026Aug 24, 2026
4Aug 18, 2026Aug 18, 2026
4Aug 14, 2026Aug 14, 2026
4Aug 14, 2026Aug 14, 2026
424B5Aug 13, 2026Aug 13, 2026
4Aug 13, 2026Aug 13, 2026
8-KAug 13, 2026Aug 13, 2026
424B5Aug 11, 2026Aug 11, 2026
8-KAug 10, 2026Aug 10, 2026

Competitors

Who does AbCellera Biologics Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about ABCL's filings, answered from its disclosures.

What is the latest ABCL filing?

The latest filing shown is 4 dated Nov 13, 2026.

How many recent filings does ABCL have?

Intrinsic Alpha currently shows 20 recent filings for ABCL.